Similar articles

• [Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].

  Kostadinova DA, Razboĭnikov S. Kostadinova DA, et al. Vutr Boles. 1976;15(2):18-26. Vutr Boles. 1976. PMID: 59467 Review. Bulgarian. No abstract available.
• [Fluorescent antibodies in lupus erythematosus].

  Gumarov VZ. Gumarov VZ. Vestn Dermatol Venerol. 1967 Feb;41(2):18-22. Vestn Dermatol Venerol. 1967. PMID: 4901524 Russian. No abstract available.
• [Clinico-immunological aspects of antinuclear antibodies in systemic lupus erythematosus].

  Speranskiĭ AI, Aroian AA, Ivanova SM, Panasiuk AF, Riazantseva TA. Speranskiĭ AI, et al. Revmatologiia (Mosk). 1987 Jul-Sep;(3):28-34. Revmatologiia (Mosk). 1987. PMID: 2446367 Russian. No abstract available.
• The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.

  Burnham TK, Neblett TR, Fine G, Bank P. Burnham TK, et al. Arch Dermatol. 1969 May;99(5):611-6. Arch Dermatol. 1969. PMID: 4889089 No abstract available.
• Subacute cutaneous lupus erythematosus.

  Gilliam JN, Sontheimer RD. Gilliam JN, et al. Clin Rheum Dis. 1982 Aug;8(2):343-52. Clin Rheum Dis. 1982. PMID: 6754230 Review. No abstract available.